Sai Life Sciences Limited · NSE: SAILIFE · BSE: 544306

Sai Life Sciences

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 06 Aug 2026.

Q1 FY27 · Consolidated

Revenue
554.28₹ Cr
+11.7% vs year ago
Net profit
73.28₹ Cr
+21.2% vs year ago
EPS, basic
3.46₹
+19.3% vs year ago
Net margin
13.2%
+1.0 pts vs year ago
Revenue₹ crore · consolidated · last 7 quarters
Q3 FY25: ₹439.78 CrQ4 FY25: ₹579.51 CrQ1 FY26: ₹496.42 CrQ2 FY26: ₹537.47 CrQ3 FY26: ₹556.46 CrQ4 FY26: ₹602.14 CrQ1 FY27: ₹554.28 CrQ3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 7 quarters
Q3 FY25: ₹53.85 CrQ4 FY25: ₹88.27 CrQ1 FY26: ₹60.45 CrQ2 FY26: ₹83.84 CrQ3 FY26: ₹100.38 CrQ4 FY26: ₹104.24 CrQ1 FY27: ₹73.28 CrQ3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026554.28+11.7%73.28+21.2%3.4606 Aug 2026
Q4 FY26Jan–Mar 2026602.14+3.9%104.24+18.1%4.9314 May 2026
Q3 FY26Oct–Dec 2025556.46+26.5%100.38+86.4%4.7705 Feb 2026
Q2 FY26Jul–Sep 2025537.47—83.84—4.0106 Nov 2025
Q1 FY26Apr–Jun 2025496.42—60.45—2.9007 Aug 2025
Q4 FY25Jan–Mar 2025579.51—88.27—4.2414 May 2025
Q3 FY25Oct–Dec 2024439.78—53.85—2.8907 Feb 2025
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026546.73+13.2%71.34+22.2%3.3606 Aug 2026
Q4 FY26Jan–Mar 2026594.34+4.8%102.53+14.0%4.8514 May 2026
Q3 FY26Oct–Dec 2025549.18+28.1%97.63+91.2%4.6405 Feb 2026
Q2 FY26Jul–Sep 2025526.67—82.95—3.9706 Nov 2025
Q1 FY26Apr–Jun 2025483.04—58.37—2.8007 Aug 2025
Q4 FY25Jan–Mar 2025567.01—89.94—4.3214 May 2025
Q3 FY25Oct–Dec 2024428.60—51.06—2.7407 Feb 2025

14 filings on record for this company.